> Karl Lauterbach, Germany, confirmed that the Kochi vaccine produced by China has been approved to be imported, but only allows to take over within the scope of the responsibility of the Chinese Embassy and consulate.Germany's Ming Mirror Weekly believes that the German Ministry of Health is released for the import of Kexing vaccine in imports, aiming to promote the process of approval by MRNA crown vaccine produced by German Biontech Company in China.NotVoice of Germany reported that Laitbach said that through this step, Chinese citizens in Germany can vaccinate their own vaccines and obtain more immune protection.Lautbach said he can imagine that some Chinese people trust the crown vaccine from China.NotImport licenses have taken effect on Wednesday (December 7).Earlier, the evaluation of the Paul-Erich Research Institute (PEI), which is responsible for vaccine review, was evaluated to the Kochi vaccine, which opened a green light for the approval procedure.Lautbach said that this assessment eliminates some of the previous concerns about the safety of the Kochi vaccine, because he has obtained sufficient data support, and he can "agree with any reserved land" to agree to the vaccine in Germany.NotThe federal government does not plan to open the vaccine to all Germans.However, with this approval, those who have been vaccinated in the future will also be regarded as "vaccination" in Germany.Previously, the corresponding proof can only be obtained by vaccination that was officially approved in Germany.NotWill the Chinese living in Germany be vaccinated in the Chinese embassy and consulate, and the media believes that the Chinese embassy in Germany in Germany has not received a reply.NotAccording to reports, the German Ministry of Health's release for imported Kexing vaccines may belong to the "swap conditions" between Berlin and Beijing, and aimed at promoting the process of approval in China in China.Reuters quoted the German Federal Government and the Ministry of Health spokesman at the end of November that the German government and the Chinese side were "in touch" in China.NotSPAN> Fosun Pharmaceutical revealed to the outside world in July 2021 that the China Drug Administration has passed the expert review of Fu Bitai , but there has been no following.During the visit to China in early November, German Chancellor State said that China will allow foreigners who live in China to vaccinate the resume -to -Pitta vaccine and agree to accelerate the approval process of the vaccine.At the time, Tsubitz believed that the Fu Bitai vaccine was generally approved in China, which was "imagined", but provided that there were closer cooperation between regulatory agencies between China and the European Union.NotShen Hongbing, deputy director of the State CDC and academician of the Chinese Academy of Engineering, said on November 17 to answer the latest progress when Fu Bitai was listed in China. At present, relevant Chinese departments have comprehensively considered safety, effectiveness, availability, and available.After the burdens and other factors, we are formulating a plan to accelerate the vaccination of coronary virus vaccine.